Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors
Jeffrey R. Infante,Antoine Hollebecque,Sophie Postel-Vinay,Todd M. Bauer,Elizabeth M. Blackwood,Marie Evangelista,Sami Mahrus,Franklin V. Peale,Xuyang Lu,Srikumar Sahasranaman,Rui Zhu,Yuan Chen,Xiao Ding,Elaine R. Murray,Jennifer L. Schutzman,Jennifer O. Lauchle,Jean-Charles Soria,Patricia M. LoRusso Clinical Cancer Research（2016）
关键词
Cancer Therapy,Tumor Suppression
AI 理解论文
溯源树
样例
